<DOC>
	<DOCNO>NCT00957437</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics different extended-release formulation AZD1305 give single multiple oral dos healthy male volunteer .</brief_summary>
	<brief_title>Study Assess Drug Concentrations Plasma Different Extended-release Formulations AZD1305</brief_title>
	<detailed_description />
	<criteria>Provision sign , write date informed consent prior study specific procedure . Body mass index ( BMI ) 19 30 kg/m2 weigh least 50 kg 100 kg . History presence clinically significant disease disorder opinion investigator . Use nicotine last 4 week screen 7 cigarette per week ( equivalent 1 nicotine patch 7 nicotine gum per week ) . There smoke followup visit . Any clinically relevant abnormal finding physical examination , clinical chemistry , haematology , urinalysis , vital sign ECG baseline opinion investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>male</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>AZD1305</keyword>
</DOC>